# AccuMedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/accumedical

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.accumedical.cn
- Total disclosed funding: $14M
- Latest round: Series B (Dec 11, 2020)
- Investors on record: 5

## About

Established in 2017 and based in Beijing, China, AccuMedical is a medical technology company that focused on developing neurovascular interventional devices. The company has an R&D center in California, USA. In December 2020, it closed series B+ funding led by returning investor Sequoia Capital. New investor Taikang Life Insurance and returning investor Huagai Capital also participated in this round. AccuMedical was recognized as Beijing Specialized, Refined, Featured and Original SME. In October 2023, the company received NMPA Marketing Approval for Attractor Intracranial Thrombus Aspiration Catheter.

The company is mainly engaged in the research and development, production and sales of interventional medical devices. Its main products are innovative neurointerventional devices for hemorrhagic stroke and ischemic stroke diagnosis and treatment and related access devices. The products are mainly used for minimally invasive treatment of cerebral aneurysms.

AccuMedical generates revenue by selling its innovative neurointerventional devices.

## Funding rounds

- Series B, Dec 11, 2020 — Hong Shan, Huagai Capital, Taikang Life Insurance
- Series B, Jul 13, 2020, $14M — Hong Shan, Huagai Capital
- Series A, Aug 2, 2019 — Beyond Capital, Proxima Ventures

## Investors

- Beyond Capital — Series A
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A
- Hong Shan — Series B
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series B
- Taikang Life Insurance — Series B